henry...just to make sure I understand...so if a patient has HIV and a low CD4 count, it will not be improved by leronlimab as it was described today for covid? I was assuming that there are other MOAs for these indications but that CD4 restoration would be common amongst all indications. Appreciate your expertise as this is not my background and I may be thinking too simplistic. TIA